Dave Spaulding

Spaulding Science Group provides executive talent search services to the life sciences and related industries. We are industry insiders with decades of managerial experience and a passion for building high-performing teams. We combine experiential knowledge and business acumen with a collaborative, personal approach to deliver the best talent available in the fields of biopharmaceuticals, medical devices, clinical laboratory science, and life science tools. Our specialties include the recruiting of leadership talent in general management, R&D, clinical affairs, regulatory affairs, quality, manufacturing, laboratory science, and other technical and scientific areas. We should know each other.

Seed stage investments in technology, SaaS, and life science companies. I often take an active role in developing strategy, business models, and fund raising for the companies that I invest in. Founding member of the Santa Barbara Angel Alliance.

Mentor to several past winners of TMP's annual New Venture Competition. Judge for the 2016 New Venture Competition. Co-Instructor for TMP149, "Creating a Market-tested Startup Business Model", which teaches the lean method of Market Validation using an iterative customer-focused process. UCSB's Technology Management Program was designed to meet the standards of today's business world. Tech Management is simultaneously redefining both business and engineering education with a comprehensive curriculum of preparation for the management and founders of tomorrow's technology ventures.

Agility Capital, LLC is a private venture debt fund focused on providing senior debt solutions to venture capital-backed private companies and Small Cap public companies.

Building connections with entrepreneurs in technology and beyond throughout the California Central Coast. The MIT Enterprise Forum hosts the region's top business and technology events. Each month, we bring together veteran business leaders and experts to host events designed to educate, inform, and inspire entrepreneurs.

Stellar developed and manufactured GMP-grade KLH (keyhole limpet hemocyanin) protein products for use as immune response modifiers in therapeutic vaccines for cancer and other serious chronic diseases. We cultivated the source animal (M. crenulata - the giant keyhole limpet mollusc) using proprietary aquaculture systems and production methods that minimized the environmental impacts on this sensitive marine species.

A UCSB spin-out, The Terosin Group was devoted to the pharmacology and pharmaceutical development of pseudopterosins, a class of marine natural products with unique anti-inflammatory and wound healing properties.

Responsible for global strategic and tactical marketing of the molecular pathology product line for oncology research and diagnostics.

Managed strategic partnerships and technology alliances with biopharmaceutical companies for oncology companion diagnostics development; M&A; technology and product licensing.

Responsible for R&D and Manufacturing of > 100 molecular pathology products for oncology diagnostics and research, including HPV ISH, leukemia and lymphoma gene rearrangement assays, and high-sensitivity multiplexed cytochemical assays.